LeMaitre Vascular Inc
NASDAQ:LMAT
LeMaitre Vascular Inc
Cash from Operating Activities
LeMaitre Vascular Inc
Cash from Operating Activities Peer Comparison
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
LeMaitre Vascular Inc
NASDAQ:LMAT
|
Cash from Operating Activities
$36.8m
|
CAGR 3-Years
2%
|
CAGR 5-Years
14%
|
CAGR 10-Years
21%
|
|
Becton Dickinson and Co
NYSE:BDX
|
Cash from Operating Activities
$3.4B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
4%
|
CAGR 10-Years
8%
|
|
Boston Scientific Corp
NYSE:BSX
|
Cash from Operating Activities
$2.5B
|
CAGR 3-Years
18%
|
CAGR 5-Years
52%
|
CAGR 10-Years
8%
|
|
Stryker Corp
NYSE:SYK
|
Cash from Operating Activities
$3.7B
|
CAGR 3-Years
4%
|
CAGR 5-Years
7%
|
CAGR 10-Years
7%
|
|
Abbott Laboratories
NYSE:ABT
|
Cash from Operating Activities
$7.3B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
4%
|
CAGR 10-Years
9%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Cash from Operating Activities
$1.7B
|
CAGR 3-Years
2%
|
CAGR 5-Years
7%
|
CAGR 10-Years
8%
|
See Also
What is LeMaitre Vascular Inc's Cash from Operating Activities?
Cash from Operating Activities
36.8m
USD
Based on the financial report for Dec 31, 2023, LeMaitre Vascular Inc's Cash from Operating Activities amounts to 36.8m USD.
What is LeMaitre Vascular Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
21%
Over the last year, the Cash from Operating Activities growth was 45%. The average annual Cash from Operating Activities growth rates for LeMaitre Vascular Inc have been 2% over the past three years , 14% over the past five years , and 21% over the past ten years .